Senior insider sale
EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$2.07M
4.27K shares
What this filing means
BUNNAGE MARK E. plans to sell 4.27K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $2.07M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2026ACC: 0001959173-26-003628
Officer· EVP, Chief Scientific Officer
Since Feb 2026
4.27K
Shares to sell
$2.07M
Approx. market value
33.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
ESPP Purchase
Cash
5/14/2026
33.00Total acquired33.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/14/2026 | ESPP Purchase Cash | 33.00 | — |
| Total | 33.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
620.00
Market value
$301.5K
2/25/2026
—Completed
Units to sell
1.18K
Market value
$559.9K
2/18/2026
—Completed
Units to sell
2.44K
Market value
$1.19M
2/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
33.00
Market value
$15.0K
5/15/2026
Total
Units
4.27K
Value
$2.07M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/25/2026 | 620.00 | $301.5K | — | Completed |
2/18/2026 | 1.18K | $559.9K | — | Completed |
2/17/2026 | 2.44K | $1.19M | — | Completed |
| Planned — Approximate Date | ||||
5/15/2026 | 33.00 | $15.0K | NASDAQ | Planned |
| Total | 4.27K | $2.07M | ||